Skip to search formSkip to main contentSkip to account menu

Depreotide

Known as: Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl), (1-1')-sulfide with 3-(2-mercaptoacetamido)-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide 
National Institutes of Health

Related topics

Related topics

1 relation

Narrower (1)

P829

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy.
PURPOSE To perform a meta-analysis to estimate the diagnostic accuracy of dynamic contrast material-enhanced computed tomography… 
2006
2006
Early prediction of endocrine therapy effect in advanced breast cancer patients using 99mTc-depreotide scintigraphy.
UNLABELLED In vitro assessment of hormone receptor status using a ligand-binding assay or immunohistochemistry in breast cancer… 
2006
2006
Characterization of radiologically indeterminate lung lesions: 99mTc-depreotide SPECT versus 18F-FDG PET
AimTo evaluate the diagnostic accuracy of 99m Tc-depreotide vs PET-18FDG scans in patients with suspicion of lung cancer Material… 
2005
2005
Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules
PurposeThe purpose of the study was to compare 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) and 99mTc… 
2004
2004
The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
STUDY OBJECTIVES The findings from conventional imaging modalities, such as chest CT, are frequently unreliable in patients with… 
Review
2002
Review
2002
Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide.
Several tumors overexpress somatostatin receptors (SSTR) and can thus be imaged with radiolabeled analogues of somatostatin. Tc… 
2002
2002
Efficacy of Tc‐99m Depreotide Scintigraphy in the Evaluation of Solitary Pulmonary Nodules
PURPOSETc-99m depreotide is a peptide analogue of a somatostatin receptor that preferentially binds to somatostatin receptors 2… 
Highly Cited
2000
Highly Cited
2000
A multicenter trial with a somatostatin analog (99m)Tc depreotide in the evaluation of solitary pulmonary nodules.
OBJECTIVE The affinity of various malignant neoplasms including small cell and non-small cell lung cancer for peptide analogs of… 
Review
2000
Review
2000
Nuclear medicine imaging of lung cancer.
Review
2000
Review
2000
Role of nuclear medicine in the evaluation of the solitary pulmonary nodule.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)